EZZ Life Science Holdings Ltd (EZZ) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.198x

Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has a cash flow conversion efficiency ratio of -0.198x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.50 Million ≈ $-3.89 Million USD) by net assets (AU$27.81 Million ≈ $19.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EZZ Life Science Holdings Ltd (EZZ) total market value for the company's overall valuation and market capitalisation.

EZZ Life Science Holdings Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how EZZ Life Science Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

EZZ Life Science Holdings Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their cash flow conversion efficiency. Explore EZZ Life Science Holdings Ltd (EZZ) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Volex Plc LSE:VLX	0.107x
City Steel Public Company Limited BK:CITY	0.004x
Vision Sigma TA:VISN	-0.017x
Klimator AB ST:KLIMAT	0.179x
Malaysian Genomics Resource KLSE:0155	0.053x
Magnum Mining and Exploration Ltd AU:MGU	-0.164x
Quoin Pharmaceuticals Ltd DRC NASDAQ:QNRX	-0.817x
Sampann Utpadan India Limited NSE:SAMPANN	-0.194x

Annual Cash Flow Conversion Efficiency for EZZ Life Science Holdings Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of EZZ Life Science Holdings Ltd from 2018 to 2024. View current stock price of EZZ Life Science Holdings Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$28.09 Million ≈ $19.87 Million	AU$4.35 Million ≈ $3.08 Million	0.155x	-46.20%
2023-12-31	AU$21.32 Million ≈ $15.09 Million	AU$6.14 Million ≈ $4.35 Million	0.288x	+4.67%
2022-12-31	AU$14.58 Million ≈ $10.32 Million	AU$4.01 Million ≈ $2.84 Million	0.275x	+64.84%
2021-12-31	AU$11.39 Million ≈ $8.06 Million	AU$1.90 Million ≈ $1.35 Million	0.167x	+565.80%
2020-12-31	AU$10.11 Million ≈ $7.15 Million	AU$253.53K ≈ $179.39K	0.025x	-93.38%
2019-12-31	AU$7.85 Million ≈ $5.56 Million	AU$2.97 Million ≈ $2.10 Million	0.379x	-25.04%
2018-12-31	AU$823.91K ≈ $582.97K	AU$416.33K ≈ $294.58K	0.505x	--

About EZZ Life Science Holdings Ltd

AU:EZZ Australia Biotechnology

Market Cap

$13.65 Million

AU$19.29 Million AUD

Market Cap Rank

#26355 Global

#1191 in Australia

Share Price

AU$0.41

Change (1 day)

-1.20%

52-Week Range

AU$0.37 - AU$3.32

All Time High

AU$4.93